Last update 01 Nov 2024

Proveca Pharma Ltd.

Private Company|
Ireland

Overview

Basic Info

Introduction
Proveca Ltd is a pharmaceutical company based in the UK that specializes in the development and licensing of medicines to address unmet medical needs in children. The company's vision is to provide licensed medicines specifically designed for children. As part of its research and development programmes, Proveca Ltd evaluates novel pharmaceutical formulations to improve dose flexibility and administration, aiming to ensure better acceptance of medicines in children.

Tags

Cardiovascular Diseases
Nervous System Diseases
Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases2
Infectious Diseases2
Immune System Diseases2
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
ACE(Angiotensin-converting enzyme)1
mAChRs(Muscarinic acetylcholine receptor)1

Related

2
Drugs associated with Proveca Pharma Ltd.
Enalapril Maleate
Target
ACE
Mechanism
ACE inhibitors
Active Org.
Proveca Pharma Ltd. [+5]
Originator Org.
Bausch Health Cos., Inc.Bausch Health Cos., Inc.
Active Indication
Ventricular Dysfunction, Left [+9]
Inactive Indication
Cardiomyopathy, Dilated [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date24 Dec 1985
Glycopyrrolate
Target
mAChRs
Mechanism
mAChRs antagonists
Active Org.
Fresenius Kabi USA LLCFresenius Kabi USA LLC [+12]
Originator Org.
Vectura Group Ltd.Vectura Group Ltd. [+1]
Active Indication
Anesthesia [+12]
Inactive Indication
Airway Obstruction [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date11 Aug 1961
2
Clinical Trials associated with Proveca Pharma Ltd.
NCT04873115 / RecruitingPhase 4
Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties,
EUCTR2020-005534-15-FR / Unknown statusPhase 4
Double-blind, placebo-controlled, randomized clinical trial comparing the efficacy and safety of Sialanar plus oral rehabilitation against placebo plus oral rehabilitation for children and adolescents with severe sialorrhoea and neurodisabilties - SALIVA study
100 Clinical Results associated with Proveca Pharma Ltd.
Login to view more data
0 Patents (Medical) associated with Proveca Pharma Ltd.
Login to view more data
100 Deals associated with Proveca Pharma Ltd.
Login to view more data
100 Translational Medicine associated with Proveca Pharma Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 31 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Enalapril Maleate
 ( ACE )		Heart Failure
More
Approved
Glycopyrrolate
 ( mAChRs )		Sialorrhea
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free